RETRONOSE
LIVE

Serial Number

79275190

Owner

LA DIFFUSION TECHNIQUE FRANCAISE

Attorney

Janet G Ricciuti

Filing Date

Nov 7, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RETRONOSE Trademark

Serial Number: 79275190 • Registration: 6274701

RETRONOSE is a trademark filed by LA DIFFUSION TECHNIQUE FRANCAISE on November 7, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

LA DIFFUSION TECHNIQUE FRANCAISE (9 trademarks)

19 rue de la Presse
F-42000 SAINT-ETIENNE , FR

Entity Type: 99

UNIVERSITE DE TOURS

60 rue du Plat d'Etain,
TOURS CEDEX 01 F-37020 , FR

Entity Type: 99

Trademark Details

Filing Date

November 7, 2019

Registration Date

February 23, 2021

Published for Opposition

December 8, 2020

Goods & Services

Medical apparatus and instruments, namely, surgical apparatus and instruments for use in general and minimally invasive surgery; Apparatus for distribution, dosage and administration of medical products, namely, aerosol dispensers and inhalers, dry powder inhalers, nebulizers, pressurized metered dose inhalers, soft mist inhalers all for medical purposes; Apparatus for distribution, dosage and administration of pharmaceutical products, namely, aerosol dispensers and inhalers, dry powder inhalers, nebulizers, pressurized metered dose inhalers, soft mist inhalers all for medical use; Apparatus in the nature of inhalers and nebulizers for administering aerosols all for medical use; Apparatus actuated by nasal expiratory phase for administering sprays for medical use, namely, nasal aspirators; Inhalers and apparatus actuated by nasal expiratory phase, namely, nasal aspirators for administering medicines for nasal, rhinological, laryngeal and oral cavity effect

Pharmaceutical products, namely, medicines and chemical preparations for medical use for the treatment of immune system related diseases and disorders, for treating or preventing of respiratory diseases and disorders, of infectious diseases, of inflammation, of upper airways cancer diseases, of radioactive contamination, of biohazard contamination, of pain, central nervous system diseases, cardiovascular diseases, metabolic diseases, of asthma, of allergies; vaccines; Medicines for medical use for the treatment of immune system related diseases and disorders, for treating or preventing of respiratory diseases and disorders, of infectious diseases, of inflammation, of upper airways cancer diseases, of radioactive contamination, of biohazard contamination, of pain, central nervous system diseases, cardiovascular diseases, metabolic diseases, of asthma, of allergies; vaccines for humans; Chemical preparations for medical use, namely, for the treatment of immune system related diseases and disorders, for treating or preventing of respiratory diseases and disorders, of infectious diseases, of inflammation, of upper airways cancer diseases, of radioactive contamination, of biohazard contamination, of pain, central nervous system diseases, cardiovascular diseases, metabolic diseases, of asthma, of allergies; vaccines; Chemical preparations for pharmaceutical use, namely, for the treatment of immune system related diseases and disorders, for treating or preventing of respiratory diseases and disorders, of infectious diseases, of inflammation, of upper airways cancer diseases, of radioactive contamination, of biohazard contamination, of pain, central nervous system diseases, cardiovascular diseases, metabolic diseases, of asthma, of allergies; vaccines

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 23, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 24, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
May 26, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
May 26, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 23, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 23, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 8, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Dec 6, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 18, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 18, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 18, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 4, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 4, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 4, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 4, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2020 CRFA
ASSIGNED TO LIE
Oct 13, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 1, 2020 TROA
REFUSAL PROCESSED BY IB
Mar 21, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 5, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 5, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 12, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 11, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 10, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 26, 2019 REPR